Biotest Pharma to expand plant, hire workers

Biotest Pharmaceuticals announced it will be expanding its plasma plant and hiring an additional 50 workers to increase production of its hepatitis treatment, Nabi HB. The Florida company has already begun construction on the $16 million expansion. According to the Palm Beach Post, Biotest is eligible to receive up to $200,000 in tex incentives from the county and state. Biotest Pharma was formerly the biologics unit at Nabi Pharmaceuticals, but was purchased by Germany's Biotest for $185 million in 2007. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.